Madrigal Pharmaceuticals
0 followers
Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.
Org chart
Bill Sibold
CEO
Bill Sibold
Collapse
Rebecca Taub
Director, Founder, CMO & President of Research & Development
Alex Howarth
CFO
Dominic F. Labriola
Chief Data and Analytics Officer
Robert Waltermire
Chief Pharmaceutical Development Officer
Brian J. Lynch
General Counsel
Edward Chiang
SVP, Clinical & Technical Operations
Thomas Hare
SVP, Clinical Management
Stephen Dodge
SVP, Global Medical Affairs
